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DObjective: The aim of the present study was to review nationwide outcomes of surgical embolectomy for acute
pulmonary embolism.
Methods: Adult patients undergoing surgical embolectomy for acute pulmonary embolism from 1999 to 2008
were identified in the weighted Nationwide Inpatient Sample. The primary endpoint was inpatient mortality.
Multivariate logistic regression analysis incorporating significant univariate predictors (P<.2) was conducted
to identify independent predictors of inpatient mortality.
Results: There were 2709 eligible patients identified as undergoing surgical embolectomy for acute pulmonary
embolism during the study period. The mean age was 57.0  16.0 years. Of the patients, 1242 (45.8%) were
women. A total of 280 patients (10.3%) had undergone thrombolysis before surgical embolectomy. The overall
inpatient mortality rate was 27.2%. On multivariate analysis, an increasing Charlson comorbidity index (odds
ratio, 1.37; 95% confidence interval, 1.12–1.69;P¼ .003) significantly increased the odds of inpatient mortality.
In addition, blacks were more than twofold more likely to die during hospitalization than whites (odds ratio,
2.29; 95% confidence interval, 1.18–4.46;P¼ .02). Although age, payment type, hospital location (urban versus
rural), hospital embolectomy volume, and surgeon embolectomy volume were associated with inpatient mortal-
ity on univariate analysis (each P<.2), none of these factors correlated with mortality in the multivariate model.
Conclusions: This large-cohort analysis of more than 2700 patients demonstrates a nationwide inpatient mor-
tality rate of 27.2% after pulmonary embolectomy. Although patient factors affect mortality, the arena of care
appears to have no significant effect on operative outcomes. This suggests that it might be more prudent for cen-
ters with qualified surgeons to avoid delays in treatment, rather than transfer care because of a perception of im-
proved outcomes. (J Thorac Cardiovasc Surg 2013;145:373-7)Approximately 300,000 people die of acute pulmonary em-
bolism (PE) in the United States annually.1,2 In the setting
of a massive PE, the infusion of heparin or a thrombolytic
agent such as alteplase is generally recommended,
although bleeding complications remain a real concern
with the latter.3,4 Surgical embolectomy is a therapeutic
option for patients who have contraindications to
thrombolysis or who have persistent hypotension after
initial therapy. Pulmonary embolectomy has also been
associated with favorable results in patients with preserved
hemodynamics but with evidence of moderate to severe
right ventricular dysfunction on echocardiography.5 Regard-
less of the indication, previous outcome analyses for
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The Journal of Thoracic and Casmall patient cohorts. In the present study, we evaluated
the nationwide outcomes of surgical embolectomy for
acute PE.
METHODS
Data Source
The Nationwide Inpatient Sample served as the data source for the pres-
ent analysis. This database is 1 of several registries initiated as a part of the
Healthcare Cost and Utilization Project, developed by the Agency for
Healthcare Research and Quality. The Nationwide Inpatient Sample con-
tains data from 1050 participating institutions in 44 states, representing
a 20% stratified sample of community hospitals.6 By using a weighting
strategy, these data reflect approximately 95% of all hospital discharges
within the United States. The database does not contain any patient or cen-
ter identifiers. Our institutional review board approved the study protocol.
Study Cohort
The study population in the present analysis consisted of adult (age18
years) patients undergoing surgical embolectomy for acute PE. The Inter-
national Classification of Diseases, Ninth Revision (ICD-9) codes were
used to identify this patient subset. Moreover, patients with acute PE
were initially identified using ICD-9 codes 415.1, 415.11, 415.12, and
415.19. Patients with PE complicating pregnancy or childbirth were ex-
cluded from the analysis (codes 634-638 with .6, 639.6, or 673.0-673.8).
Pulmonary surgical embolectomy was identified by the ICD-9 code
38.05. The use of thrombolytics was identified by code 99.10.
Statistical Analysis
The primary outcome of interest was inpatient mortality, defined as
death occurring during the admission in which surgical embolectomyrdiovascular Surgery c Volume 145, Number 2 373
Abbreviations and Acronyms
ICD-9 ¼ International Classification of Diseases,
Ninth Revision
PE ¼ pulmonary embolism
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on inpatient mortality. The patient and clinical variables included age, gen-
der, race, payment type (self-pay or private insurance,Medicare, Medicaid,
or other), Charlson comorbidity index, and the use of thrombolytics. Hos-
pital variables included teaching status, location (urban or rural), size
(small, medium, or large as coded in the database), hospital procedural vol-
ume, and surgeon procedural volume.
The baseline patient and hospital characteristics were initially compared
between embolectomy patients surviving to discharge and those who did
not. Univariate logistic regression analysis was also conducted for each
of these patient and hospital variables. Those covariates associated with in-
patient mortality on univariate analysis (P<.2) were entered into a multi-
variate logistic regression model.
All frequency data are presented as percentages, and all continuous
data as the mean  standard deviation. Since the Nationwide Inpatient
Sample was composed of weighted data, survey statistics were used to
make comparisons. Moreover, a design-based Pearson chi-square test
was used for comparisons of categorical data, and the adjusted Wald
test was used for comparisons of continuous data. All analyses were
performed using STATA software, version 11 (StataCorp, College
Station, Tex).RESULTS
Baseline Characteristics
A total of 2709 eligible adult patients were identified as
undergoing surgical embolectomy for acute PE during the
study period. The mean age was 57.0  16.0 years, and
1242 patients (45.8%) were women (Table 1). Most pa-
tients were white (74.0%; n ¼ 1553) and privately insured
or self-pay (49.2%; n ¼ 1333).
The overall inpatient mortality rate was 27.2%. The
mean length of hospitalization was 15.5  18.9 days. The
patients who had an operative mortality had a significantly
shorter length of hospital stay (11.8  20.1 days) than the
survivors (16.8  18.3 days; P ¼ .01). Nonsurvivors were
significantly older (P ¼ .01) than the survivors and had
a greater mean Charlson comorbidity index (P ¼ .002).
Otherwise, the survivors and nonsurvivors were similar
with regard to gender, race, payment status, and the use of
thrombolytics before surgical embolectomy.
Most patients underwent pulmonary embolectomy at
teaching institutions (73.5%; n ¼ 1992) that were located
in an urban region (97.1%; n ¼ 2630). Nonsurvivors un-
derwent pulmonary embolectomy at hospitals with a lower
annual embolectomy volume (P ¼ .04; Table 2). Simi-
larly, nonsurvivors underwent pulmonary embolectomy
by surgeons with lower average procedural volumes
(P ¼ .02). The teaching status, location, and size of hos-
pitals were comparable between the survivors and
nonsurvivors.374 The Journal of Thoracic and Cardiovascular SurgLogistic Regression Analysis
Seven covariates were found to be associated with inpa-
tient mortality after pulmonary embolectomy in our univar-
iate logistic regression analysis (each P < .2). Those
covariates included age, race, Charlson comorbidity index,
payment type, hospital location, hospital embolectomy vol-
ume, and surgeon embolectomy volume. On multivariate
logistic regression analysis incorporating these 7 variables,
only 2 variables persisted as significant risk factors for inpa-
tient mortality: increasing comorbidity index and black
race.Moreover, for each 1-point increase in the comorbidity
index, there was a 37% increase in inpatient mortality
(P ¼ .003; Table 3). With respect to race, blacks were
129% more likely to die after surgical embolectomy than
whites (P ¼ .02).
None of the hospital characteristics was found to inde-
pendently predict operative mortality on multivariate anal-
ysis. In limiting the analysis to urban centers, in which the
vast majority of patients underwent embolectomy (97.1%),
the operative mortality rates were comparable after stratify-
ing patients according to teaching status and size of the in-
stitution (Figure 1). Furthermore, to ensure that delays in
treatment that could possibly occur with the transfer of pa-
tients were not significantly accounting for the comparable
outcomes between hospitals, a secondary analysis was per-
formed that excluded transferred patients. The operative
mortality in this subanalysis remained comparable among
the various types of hospitals stratified according to teach-
ing status, size, and location (each P>.05).
DISCUSSION
Selecting the initial therapeutic strategy for PE generally
depends on assessing the mortality risk from the embolic
load and the risk of bleeding from thrombolytic agents.
Heparin is recommended for patients who are hemodynam-
ically stable and have no evidence of right ventricular dys-
function on echocardiography, because they represent the
cohort with the lowest PE-related mortality risk. In patients
with submassive PE, defined by hemodynamic stability but
echocardiographic evidence of right ventricular dysfunc-
tion, the utility of thrombolysis is controversial, with a ran-
domized study failing to demonstrate a significant reduction
in mortality compared with heparin alone.7 Favorable re-
sults with surgical embolectomy in submassive PE have
been reported.8,9 In the case of massive PE with
hemodynamic instability, a meta-analysis of several ran-
domized trials demonstrated a significant reduction in re-
current PE or death with thrombolysis compared with
heparin, but an international multicenter registry found no
such reduction.3,10 In addition to its increasing use in
submassive PE, surgical embolectomy is generally
recommended in cases of persistent hemodynamic
instability after initial systemic thrombolysis, in cases of
massive PE in which thrombolysis is contraindicatedery c February 2013
TABLE 1. Baseline patient and clinical differences stratified by survival to discharge
Variable All patients (n ¼ 2709) Survivors (n ¼ 1972) Operative mortality (n ¼ 737) P value*
Age (y) 57.0  16.0 55.9  15.8 60.0  16.1 .01
Women 1242/2709 (45.8) 880/1972 (44.6) 362/737 (49.1) .42
Race .17
White 1553/2099 (74.0) 1209/1572 (76.9) 344/527 (65.3)
Black 347/2099 (16.5) 229/1572 (14.6) 118/527 (22.4)
Hispanic 84/2099 (4.0) 61/1572 (3.9) 23/527 (4.4)
Other 115/2099 (5.5) 73/1572 (4.6) 42/527 (8.0)
Charlson comorbidity index 1.9  1.1 1.8  1.0 2.2  1.2 .002
Payment status .17
Self-pay or privately insured 1333/2709 (49.2) 1017/1972 (51.6) 316/737 (42.9)
Medicare 1057/2709 (39.0) 712/1972 (36.1) 345/737 (46.8)
Medicaid 211/2709 (7.8) 165/1972 (8.4) 46/737 (6.2)
Other 108/2709 (4.0) 78/1972 (4.0) 30/737 (4.1)
Thrombolysis 280/2709 (10.3) 196/1972 (9.9) 84/737 (11.4) .65
Continuous data are presented as mean  standard deviation and frequency data as n (%). *P value for comparison between survivors to discharge and patients with operative
mortality.
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not sufficient time to infuse thrombolytic agents.11
Study Rationale
Most of the previous data describing the outcomes of
surgical embolectomy in the setting of acute PE have
been handicapped by small patient cohorts, ranging from
7 to 47 subjects in the modern era.5,9,12-15 In our study,
we reviewed the nationwide outcomes of surgical
embolectomy for acute PE in a large cohort of more than
2700 patients. Particular attention was paid to the patient
and hospital factors that predicted inpatient mortality.
Inpatient Mortality
A principal finding in our analysis was that surgical em-
bolectomy was associated with a high inpatient mortality of
27.2%. This was not surprising, given that acute PE, in and
of itself, is known to be associated with significant mortality
risk, especially when prompt diagnosis and treatment are
not initiated. The International Cooperative Pulmonary Em-
bolism Registry studied more than 2450 patients from mul-
tiple centers and found an all-cause 14-day and 90-day
mortality rate of 11.4% and 17.4%, respectively, in all pa-
tients with PE.10 The mortality rates are particularly high inTABLE 2. Baseline hospital differences stratified by survival to discharge
Variable All patients (n ¼ 2709) Survivors
Teaching hospital 1992/2709 (73.5) 1468/19
Urban location 2630/2709 (97.1) 1932/19
Hospital size
Small 77/2709 (2.8) 59/19
Medium 449/2709 (16.6) 347/19
Large 2183/2709 (80.6) 1566/19
Hospital annual volume 2.3  1.6 2.4
Surgeon annual volume 0.7  0.7 0.8
Continuous data are presented as mean  standard deviation and frequency data as n (%).
mortality.
The Journal of Thoracic and Cacases of PE with associated cardiac arrest, cardiogenic
shock, or hypotension, at about 60%, 23%, and 14%,
respectively.16
With regard to the outcomes after embolectomy, there
have been several reports of institutional experiences in
the modern era. A study of 47 patients reported a low oper-
ative mortality of 6%.9 Importantly, however, a significant
proportion of patients in their analysis were hemodynami-
cally stable, with right ventricular dysfunction as the indica-
tion for surgery. Similarly, an analysis of 29 patients
demonstrated a 30-day mortality of 11%, again with
some patients being hemodynamically stable, with right
ventricular dysfunction as the surgical indication.5 These
reports have raised the notion that an aggressive approach
with early surgical intervention before hemodynamic insta-
bility ensues might be associated with favorable outcomes,
although another recent study of 25 critically ill patients re-
ceiving inotropic support and undergoing embolectomy for
acute PE also demonstrated excellent outcomes, with an op-
erative mortality of 8%.12
Although the optimal timing for surgical intervention re-
mains to be determined, it does appear that operative mor-
tality rates, in general, have improved over time.17 In
a recent review, the cumulative operative mortality for(n ¼ 1972) Operative mortality (n ¼ 737) P value*
72 (74.4) 523/737 (71.0) .43
72 (98.0) 698/737 (94.7) .08
.42
72 (3.0) 18/737 (2.4)
72 (17.6) 102/737 (13.8)
72 (79.4) 617/737 (83.7)
 1.7 2.1  1.3 .04
 0.7 0.6  0.6 .02
*P value for comparison between survivors to discharge and patients with operative
rdiovascular Surgery c Volume 145, Number 2 375
TABLE 3. Multivariate logistic regression analysis* for inpatient
mortality after pulmonary embolectomy
Covariate OR (95% CI) P value
Age (increasing) 1.02 (1.00–1.03) .11
Charlson Comorbidity Index (increasing) 1.37 (1.12–1.69) .003
Race
White Reference
Black 2.29 (1.18–4.46) .02
Hispanic 1.60 (0.40–6.41) .50
Other 2.15 (0.85–5.41) .10
Payment type
Private or self-pay Reference
Medicare 1.90 (0.78–4.64) .16
Medicaid 2.18 (0.70–6.83) .18
Other 2.27 (0.61–8.49) .22
Rural hospital 2.65 (0.62–11.3) .19
Hospital annual volume (decreasing) 1.06 (0.90–1.24) .47
Surgeon annual volume (decreasing) 1.24 (0.83–1.86) .29
OR, Odds ratio; CI, confidence interval. *Variables included in multivariate model
were associated (P< .2) with inpatient mortality on univariate logistic regression
analysis.
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Dsurgical embolectomy was found to have significantly im-
proved from 30% to 35% before 1999 to 19% thereafter.18
Whether this reduction in mortality rates has resulted from
earlier diagnosis, better surgical techniques, improved peri-
operative care, and/or changes in the process of care that
might reduce the interval to treatment remains unknown.Predictors of Mortality
Several studies have suggested that the severity of hemo-
dynamic instability correlates with mortality after surgical
embolectomy. More specifically, patients experiencing car-
diac arrest and requiring cardiopulmonary resuscitation be-
fore surgical embolectomy have been demonstrated to be at
greater risk of postoperative mortality in these studies.13,19
This notion has been contradicted, however, by more recent
reports of low operative mortality even in patients with
preoperative cardiac arrest.12 In our study, we did not in-
clude cardiopulmonary resuscitation in the multivariate
model, because we could not determine whether cardiacFIGURE 1. Operative mortality in urban hospitals, stratified by teaching
status and hospital size.
376 The Journal of Thoracic and Cardiovascular Surgarrest occurred pre- or postoperatively in the Nationwide In-
patient Sample.
In our analysis, increasing comorbidity index and black
race were independent predictors of operative mortality. Al-
though the finding that a greater comorbidity burden corre-
lated with increased mortality was not unexpected, we were
surprised to find that racial disparities in outcomes persisted
after adjusting for other patient and hospital factors. It is un-
clear from our analysis whether this observed effect of race
on inpatient mortality after embolectomy relates to biologic
or socioeconomic factors, or both. A previous analysis of
more than 15,000 patients inclusive of all patients with
PE, regardless of therapeutic modality, similarly found
that blacks had significantly greater odds of 30-day mortal-
ity relative to white.20 This finding was also similar to our
analysis in that this effect was independent of other patient
or clinical factors such as insurance status and hospital
volume.
Hospital Factors
Surgical embolectomy is generally not a complex, tech-
nically challenging operation. This could at least partially
explain why surgeon procedural volume did not affect the
operative outcomes in our analysis. However, one could
postulate that the hospital procedural volume should affect
the operative outcomes because institutions with more ex-
perience in performing embolectomy might have standard-
ized clinical pathways in place and might have better
optimized processes of care that lead to earlier diagnosis
and treatment. This, however, was not found in our study,
perhaps because the annual hospital volumes were so low,
with only 2.3 cases performed annually on average.
In addition to procedural volume, none of the other hos-
pital or system factors were found to correlate with opera-
tive mortality. These findings persisted after excluding
patients who were transferred from other hospitals. There-
fore, we believe these data collectively suggest that the
arena of care has no significant effect on outcomes after pul-
monary embolectomy and that patient factors are more im-
portant. As such, from our analysis, it appears that
transferring patients because of a perception of improved
outcomes should be avoided, provided a qualified surgeon
is available to perform the embolectomy, especially given
the risk of clinical deterioration during the delay in treat-
ment that would accompany such transfers.
Study Limitations
A major study limitation was that we were unable to in-
clude certain variables that might have affected operative
mortality, such as hemodynamic instability or cardiac arrest
occurring before surgical intervention. Although ICD-9 co-
des are available for these, it is unclear from the Nationwide
Inpatient Sample in which sequence these adverse events
occurred in relation to the surgical embolectomy. Otherery c February 2013
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to initial treatment also were not included. We also did not
examine the use of catheter-based embolectomy in the pres-
ent analysis. In terms of procedural volume, we only evalu-
ated pulmonary embolectomy volumes, although one could
postulate that the overall cardiac volume or volume of
cardiopulmonary bypass cases could have an effect on the
outcomes of embolectomy. Finally, there are inherent limi-
tations to large administrative data sets, including the Na-
tionwide Inpatient Sample, that we could not eliminate,
including errors in data entry and missing data.CONCLUSIONS
We analyzed more than 2700 cases of surgical embolec-
tomy for acute PE in this nationwide cohort. Overall inpa-
tient mortality was 27.2%. Significant predictors of
inpatient mortality after embolectomy were limited to pa-
tient factors and included increasing comorbidity burden
and race. Additional research to delineate the causes for
these racial disparities in outcomes is warranted. Further-
more, hospital factors such as procedural volume, teaching
status, or hospital size had no independent effect on the out-
comes. These data collectively suggest that it might be more
prudent for centers with qualified surgeons to avoid delays
in treatment rather than transfer care on the basis of a per-
ception of improved outcomes. This is especially important
when considering that such delays that often accompany
a transfer of care can lead to clinical deterioration of the pa-
tient and exponential increases in mortality risk.References
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